We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

varenicline Nitroso Impurity 3

Chemical Structure
Specifications
Product name
varenicline Nitroso Impurity 3
SRC CAT No
SRC-N014253
CAS No
2803960-64-5
Mol.F.
C11H14N4O
Mol.Wt.
218.3 g/mole
Related CAS No.
NA
Inv Status
IN STOCK
Chemical Structure
Chemical Structure
view file icon VIEW COA

Chemical Name
3-Nitroso-2,3,4,5-tetrahydro-1H-1,5-methanobenzo[d]azepine-7,8-diamine

HSN Code
38229010
Synonym
N.A

Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Varenicline is used as a smoking cessation aid to help people stop smoking in conjunction with education and counseling. Varenicline is the first drug of choice for smoking cessation because it has demonstrated a significant effect in preventing both short-term and long-term relapse. varenicline Nitroso Impurity 3 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.

varenicline Nitroso Impurity 3 CAS NO:2803960-64-5 chemically represented as 3-Nitroso-2,3,4,5-tetrahydro-1H-1,5-methanobenzo[d]azepine-7,8-diamine . Synchemia is the leading manufacturing and exporter of varenicline Nitroso Impurity 3.We supply varenicline Nitroso Impurity 3 with detailed characterization data compliance with regulatory guidelines.